Impact

The SmILE project is expected to generate a long-term impact across scientific, economic, and societal domains. By developing data-driven, personalised solutions for musculoskeletal non-communicable diseases (MSK-NCDs) in older adults, SmILE will contribute to healthier ageing and more sustainable healthcare systems.

• Scientific Impact

  • New knowledge base for the prevention, diagnosis, and treatment of musculoskeletal non-communicable diseases (MSK-NCDs)
  • Demonstration of embedded sensor technologies in implants and assistive devices for real-time, personalised monitoring
  • Increased adoption of digital technologies, including AI and the Internet of Medical Things (IoMT), in geriatric care
  • Establishment of high-quality datasets to support further research into MSK health and ageing
  • Creation of research infrastructure for long-term musculoskeletal health monitoring

• Economic Impact

  • Reduced healthcare costs through earlier diagnosis, improved treatment outcomes, and lower rates of hospitalisation and long-term care
  • Support for industrial innovation in medical devices, wearables, and AI solutions
  • Strengthened European competitiveness through job creation and leadership in digital health technologies
  • Diversification of global supply chains for MSK-related medical products
  • Stimulus for emerging markets in sensor-driven, personalised healthcare

• Societal Impact

  • Improved quality of life for older adults and their caregivers through better mobility, reduced pain, and greater independence
  • Enhanced access to personalised and affordable health platforms, especially for older or underserved populations
  • Promotion of digital inclusion, leveraging the growing tech engagement of older citizens
  • Increased health literacy and empowerment among patients through access to personal health data and tailored feedback
  • Support for European public health goals, including healthy ageing and sustainable healthcare systems